These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 13265796)

  • 1. Immunological discrimination between the blood of normal and of tumour-bearing rats.
    DARCY DA
    Nature; 1955 Oct; 176(4483):643-4. PubMed ID: 13265796
    [No Abstract]   [Full Text] [Related]  

  • 2. Further observations on tumour-enhancing factors: their bearing on the immunological theory of cancer.
    GREEN HN; WILSON R
    Nature; 1958 Oct; 182(4642):1054-8. PubMed ID: 13590225
    [No Abstract]   [Full Text] [Related]  

  • 3. THE COMPLEMENT CONTENT OF THE SERUM OF NORMAL AS OPPOSED TO TUMOUR BEARING MICE.
    HARTVEIT F
    Br J Cancer; 1964 Dec; 18(4):714-20. PubMed ID: 14264936
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunity to transplanted tumour: the effect of tumour extracts on the growth of homologous tumours in rats.
    BALDWIN RW
    Br J Cancer; 1955 Dec; 9(4):646-51. PubMed ID: 13304227
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunological observations in conditioned rats with human tumor heterotransplants].
    RICCI C; TELLER MN; LARDIS MP
    Cancro; 1961; 14():441-57. PubMed ID: 14491857
    [No Abstract]   [Full Text] [Related]  

  • 6. Tumour specificity and immunological suppression.
    LEVI E; SCHECHTMAN AM; SHERINS RS; TOBIAS S
    Nature; 1959 Aug; 184(Suppl 8)():563-5. PubMed ID: 14416174
    [No Abstract]   [Full Text] [Related]  

  • 7. THE EFFECT OF INTRAPERITONEAL INJECTION OF THORACIC DUCT LYMPHOCYTES FROM NORMAL AND IMMUNIZED RATS IN MICE INOCULATED WITH THE LANDSCHUTZ ASCITES TUMOUR.
    WOODRUFF MF; SYMES MO; ANDERSON NF
    Br J Cancer; 1963 Sep; 17(3):482-7. PubMed ID: 14062496
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of phenoxybenzamine, propranolol, phenylephrine and isoproterenol on the circulation of rats bearing Guérin carcinoma.
    Debreczeni LA; Farsang C; Takács L
    Acta Physiol Acad Sci Hung; 1980; 56(4):341-65. PubMed ID: 7197111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low expression of MRP1/GS-X pump ATPase in lymphocytes of Walker 256 tumour-bearing rats is associated with cyclopentenone prostaglandin accumulation and cancer immunodeficiency.
    Kolberg A; Rosa TG; Puhl MT; Scola G; da Rocha Janner D; Maslinkiewicz A; Lagranha DJ; Heck TG; Curi R; de Bittencourt PI
    Cell Biochem Funct; 2006; 24(1):23-39. PubMed ID: 16170839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in human tumour immunology and immunotherapy.
    Rosenberg SA
    Nature; 2001 May; 411(6835):380-4. PubMed ID: 11357146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological properties of photodynamically inactivated tumour cells.
    BELLIN JS
    Nature; 1962 Jun; 194():851-2. PubMed ID: 13866902
    [No Abstract]   [Full Text] [Related]  

  • 12. Localization of radioiodinated antibodies in rats bearing tumors induced by N-2-fluorenylacetamide.
    DAY ED; PLANINSEK JA; PRESSMAN D
    J Natl Cancer Inst; 1960 Oct; 25():787-802. PubMed ID: 13720336
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanism of antigen transformation of transplantable rat tumour.
    DUX K; RYZEWSKA A; CZARNOMSKA A
    Nature; 1961 Apr; 190():458-9. PubMed ID: 13725319
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunological responses elicited in the heterologous host by transplantable human tumors: use of the conditioned rat as a test medium.
    TOOLAN HW
    Ann N Y Acad Sci; 1957 Dec; 69(4):830-41. PubMed ID: 13488335
    [No Abstract]   [Full Text] [Related]  

  • 15. [IMMUNOLOGICAL CHANGES COMMON TO DIFFERENT EXPERIMENTAL TUMORS].
    DUFOUR D
    Laval Med; 1963 Sep; 34():831-3. PubMed ID: 14052078
    [No Abstract]   [Full Text] [Related]  

  • 16. [TREATMENT RESEARCH WITH IMMUNE SERUMS IN RATS BEARING EXPERIMENTALLY TRANSPLANTED TUMORS. (EXPERIMENTAL RESEARCH). V].
    TENDELLA E; GELMI G
    Acta Chir Ital; 1963; 19():1167-77. PubMed ID: 14121897
    [No Abstract]   [Full Text] [Related]  

  • 17. IMMUNOLOGICAL tolerance in tumour studies; adaptation of ascites tumours to homologous or heterologous hosts; discussion.
    Proc R Soc Lond B Biol Sci; 1956 Nov; 146(922):57-8. PubMed ID: 13379351
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of immunological attenuation on cell dosage required to establish single or double tumour homografts.
    VAN DEN BRENK HA
    Br J Cancer; 1961 Dec; 15(4):798-803. PubMed ID: 13924532
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumour immunology and evolution of the placenta.
    Sinkovics JG; DiSaia PJ; Rutledge FN
    Lancet; 1970 Dec; 2(7684):1190-1. PubMed ID: 4098464
    [No Abstract]   [Full Text] [Related]  

  • 20. [IMMUNOLOGICAL STRAIN SPECIFICITY OF ASCITES HEPATOMA].
    HIRAI H
    Saishin Igaku; 1965 Apr; 20():989-94. PubMed ID: 14317192
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.